Form D — ASCENDIA PHARMACEUTICALS, INC.
0001855888-25-000001 · filed Jun 4, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $2,500,000
- Reported amount sold
- $2,500,000
- Minimum investment
- $100,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ASCENDIA PHARMACEUTICALS, INC.
- CIK
- 1855888
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 661 US HIGHWAY ONE
NORTH BRUNSWICK, New Jersey 08902 - Phone
- 16099320856
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jingjun Huang · Executive OfficerNew Brunswick, New Jersey Find on LinkedIn ↗
-
Robert Bloder · DirectorNew Brunswick, New Jersey Find on LinkedIn ↗
-
Shoufeng Li · DirectorNew Brunswick, New Jersey Find on LinkedIn ↗
-
James Gale · DirectorNew Brunswick, New Jersey Find on LinkedIn ↗
-
Theron Odlaug · DirectorNew Brunswick, New Jersey Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗